| Bio-Link News |
|
29/8/2016 -Bio-Link engaged by ShenQi Pharmaceutical (China) to scout for IVF company partners…more 28/7/2016 – Bio-Link published in latest issue of Australasian Biotechnology…more 25/07/2016 - Bio-Link licenses PatSnap…more 24/12/2015 – Bio-Link has been engaged by Oncology Venture to partner its clinical stage precision oncology drug candidates…more 8/12/2015 – Australian Government announces the National Innovation and Science Agenda…more |
| Client News |
|
29/08/2016 – Oncology Venture – First metastatic breast cancer patient with LiPlaCis™ confirmed partial response…more. 01/03/2016 – Oncology Venture Sweden AB has licensed LiPlaCis™ from LiPlasome Pharma. Both companies are Bio-Link clients. (Press Release) 11/12/2015 – Children’s Medical Research Institute was awarded an A$10 million grant from the ACRF for…more |
| Industry News |
|
Fri, Sep 23, 2016
Source: BioSpace |
| Welcome to Bio-Link |
|
Bio-Link is a strategic consulting and biotechnology business development company that works with Australian and international life sciences companies and academic institutions to facilitate deals based on strategic technology analysis and consulting, business development, project management and deal negotiation. Bio-Link also provides technology scouting and representation services for Australian and international companies. Bio-Link has offices in Melbourne and Sydney. Please explore our website to learn more about Bio-Link’s services and client endorsements and our portfolio of client technologies. Follow @BioLinkAus |
Bio-Link employs PatSnap IP Analytics |
Bio-Link is a proud member of
|
